首页 > 市场调查报告书 > 医疗设备

e保健行动医疗

智慧糖尿病管理市场规模、份额及成长分析（按设备、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902524

智慧糖尿病管理市场规模、份额及成长分析（按设备、应用、最终用户和地区划分）－2026-2033年产业预测

Smart Diabetes Management Market Size, Share, and Growth Analysis, By Device Type (Handheld, Wearable), By Application (Type 1 Diabetes, Type 2 Diabetes), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球智慧糖尿病管理市场规模预计在 2024 年达到 69.3 亿美元，从 2025 年的 79.5 亿美元成长到 2033 年的 238.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 14.7%。

受医疗技术进步和对个人化解决方案日益增长的需求推动，全球智慧糖尿病管理市场正经历显着扩张。关键成长要素包括人们对糖尿病护理意识的提高、全球糖尿病患者数量的增长以及对能够简化监测和治疗流程的创新设备的需求。製造商和医疗保健提供者正积极开发智慧型装置、穿戴式装置和行动应用程序，以提高糖尿病患者的生活质量，最终改善疾病管理并最大限度地减少併发症。将人工智慧 (AI) 和数据分析融入这些解决方案，为更个人化的糖尿病照护提供了广阔的前景。随着健康和福祉持续成为全球关注的焦点，预计该市场将保持持续成长，为不断扩大的糖尿病患者群体提供尖端解决方案。

全球智慧糖尿病管理市场驱动因素

全球智慧糖尿病管理市场的主要驱动因素之一是全球糖尿病盛行率的不断上升，以及肥胖率的上升和久坐生活方式的盛行。随着糖尿病的日益普遍，创新管理解决方案的需求也随之增长。穿戴式装置、行动应用程式和持续血糖监测系统等智慧糖尿病管理技术能够为患者提供即时数据和健康状况分析。这种向个人化和主动式健康管理的转变不仅提高了患者的参与度，还有助于改善整体治疗效果，从而进一步推动市场扩张，并吸引对糖尿病护理相关新技术和解决方案的投资。

限制全球智慧糖尿病管理市场的因素

全球智慧糖尿病管理市场的主要限制因素之一是先进监测设备和数位化医疗解决方案的高成本。许多醣尿病患者，尤其是在医疗预算有限的中低收入地区，都感受到采用这些创新技术所带来的经济负担。此外，缺乏智慧糖尿病管理工具的报销政策也阻碍了医疗专业人员和患者的使用。再者，患者技术素养水平的差异也影响了这些设备的有效使用，进一步阻碍了市场成长，限制了智慧糖尿病管理解决方案的广泛应用。

全球智慧糖尿病管理市场趋势

全球智慧糖尿病管理市场正经历强劲成长，主要驱动力是全球糖尿病盛行率的不断攀升。随着人口老化和久坐生活方式的日益普遍，糖尿病发病率持续上升，导致患者群体不断扩大，对先进管理解决方案的需求也日益增长。这种人口结构的变化推动了对创新技术的需求，这些技术能够改善糖尿病监测、个人化护理和即时数据分析。随着医疗保健系统将有效的管理策略置于优先地位，对智慧型装置、行动应用程式和远端医疗服务的投资激增，为满足患者和医疗保健提供者不断变化的需求的综合糖尿病管理解决方案创造了充满活力的环境。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories（United States）
Dexcom, Inc.（United States）
Medtronic plc（Ireland）
Insulet Corporation（United States）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bayer AG（Germany）
Ascensia Diabetes Care Holdings AG（Switzerland）
Tandem Diabetes Care, Inc.（United States）
LifeScan, Inc.（United States）
AgaMatrix, Inc.（United States）
Glooko, Inc.（United States）
DarioHealth Corp.（Israel）
One Drop（United States）
Ypsomed Holding AG（Switzerland）
ARKRAY, Inc.（Japan）
ACON Laboratories, Inc.（United States）
Becton, Dickinson and Company（United States）
Care Innovations, LLC（United States）
Health2Sync, Inc.（Taiwan）
Emperra GmbH E-Health Technologies（Germany）

结论与建议

简介目录

Product Code: SQMIG35A2780

Global Smart Diabetes Management Market size was valued at USD 6.93 Billion in 2024 and is poised to grow from USD 7.95 Billion in 2025 to USD 23.81 Billion by 2033, growing at a CAGR of 14.7% during the forecast period (2026-2033).

The global smart diabetes management market is experiencing significant expansion driven by advancements in healthcare technology and an increasing emphasis on personalized solutions. Key growth factors include heightened awareness around diabetes care, a rising global diabetic population, and the demand for innovative devices that streamline monitoring and treatment processes. Manufacturers and healthcare providers are actively creating smart devices, wearables, and mobile applications to enhance life quality for diabetes patients, ultimately improving disease management and minimizing complications. The integration of artificial intelligence and data analytics into these solutions presents promising opportunities for more tailored diabetes care. As health and wellness continue to be prioritized globally, the market is poised for sustained growth, providing cutting-edge solutions for an expanding demographic of diabetes sufferers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Diabetes Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Diabetes Management Market Segments Analysis

Global Smart Diabetes Management Market is segmented by Device Type, Application, End User and region. Based on Device Type, the market is segmented into Handheld and Wearable. Based on Application, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other. Based on End User, the market is segmented into Hospitals, Home Care Settings, Specialty Clinics and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Diabetes Management Market

One of the key market drivers for the global smart diabetes management market is the increasing prevalence of diabetes worldwide, compounded by rising obesity rates and sedentary lifestyles. As diabetes becomes more commonplace, the demand for innovative management solutions also grows. Smart diabetes management technologies, including wearable devices, mobile applications, and continuous glucose monitoring systems, empower patients with real-time data and insight into their health. This shift toward personalized and proactive health management is not only enhancing patient engagement but also improving overall treatment outcomes, further fueling market expansion and attracting investments in new technologies and solutions tailored for diabetes care.

Restraints in the Global Smart Diabetes Management Market

One of the key market restraints for the global smart diabetes management market is the high cost associated with advanced monitoring devices and digital healthcare solutions. Many patients with diabetes may find it challenging to afford these innovative technologies, particularly in low- to middle-income regions where healthcare budgets are constrained. Additionally, the lack of reimbursement policies for smart diabetes management tools discourages widespread adoption among healthcare professionals and patients. Furthermore, varying levels of technological literacy among patients can hinder the effective utilization of these devices, creating further barriers to market growth and limiting the accessibility of smart diabetes management solutions.

Market Trends of the Global Smart Diabetes Management Market

The Global Smart Diabetes Management market is witnessing robust growth, primarily driven by the rising prevalence of diabetes worldwide. With an aging population and increasingly sedentary lifestyles, the incidence of diabetes continues to escalate, fostering a larger patient base that necessitates advanced management solutions. This shift in demographics is propelling the demand for innovative technologies that improve diabetes monitoring, personalized care, and real-time data analytics. As healthcare systems prioritize effective management strategies, investments in smart devices, mobile applications, and telehealth services are surging, creating a dynamic landscape for comprehensive diabetes management solutions that cater to the evolving needs of patients and healthcare providers alike.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape
Startup Analysis
Patent Analysis

Global Smart Diabetes Management Market Size by Device Type & CAGR (2026-2033)

Market Overview
Continuous Glucose Monitoring Systems
Smart Insulin Pens
Smart Insulin Pumps
Smart Glucose Meters
Other

Global Smart Diabetes Management Market Size by Device Type & CAGR (2026-2033)

Market Overview
Handheld
Wearable

Global Smart Diabetes Management Market Size by Application & CAGR (2026-2033)

Market Overview
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Other

Global Smart Diabetes Management Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Home Care Settings
Specialty Clinics
Other

Global Smart Diabetes Management Market Size & CAGR (2026-2033)

North America (Device Type, Device Type, Application, End User)
- US
- Canada
Europe (Device Type, Device Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Device Type, Device Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Device Type, Device Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Device Type, Device Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ascensia Diabetes Care Holdings AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeScan, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glooko, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DarioHealth Corp. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
One Drop (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Care Innovations, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health2Sync, Inc. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments